Experience with DOVATO in the clinical setting
This browser is no longer supported.
To provide you with the best possible experience, we kindly ask you to switch to a supported browser:
Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie . Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
Dovato is a registered trade mark of the ViiV Healthcare group of companies or its licensor.
Date of preparation: October 2022 PM-IE-DLL-WCNT-200022